Invesco Health Care Fund Class C (GTHCX)
NASDAQ · Mutual Fund · Delayed Price · Currency is USD
16.42
+0.14 (0.86%)
At close: Apr 1, 2026

GTHCX Holdings Information

GTHCX is a mutual fund with a total of 78 individual holdings. The top holdings are Eli Lilly and Company stock at 9.55%, Boston Scientific at 5.10%, AbbVie at 5.02%, Cencora at 4.73%, and Gilead Sciences at 3.89%.

Total Holdings
78
Top 10 Percentage
44.66%
Asset Class
Equity
Fund Category
Health
Assets
1.23B
Forward PE Ratio
22.28

Breakdown by Sector

Top 25 Holdings

No.SymbolName WeightShares
1LLYEli Lilly and Company9.55%113,267
2BSXBoston Scientific Corporation5.10%670,569
3ABBVAbbVie Inc.5.02%277,017
4CORCencora, Inc.4.73%162,214
5GILDGilead Sciences, Inc.3.89%337,004
6AZNAstraZeneca PLC3.80%504,742
7ARGXargenx SE3.62%52,976
8JNJJohnson & Johnson3.41%184,830
9MCKMcKesson Corporation3.21%47,553
10TMOThermo Fisher Scientific Inc.2.33%49,606
11HCAHCA Healthcare, Inc.1.96%49,432
12ISRGIntuitive Surgical, Inc.1.87%45,537
13TRPXXShort-Term Investment Trust - Invesco Treasury Portfolio1.84%22,695,004
14WELLWelltower Inc.1.84%120,441
15GHGuardant Health, Inc.1.76%189,772
16ASNDAscendis Pharma A/S1.74%94,558
17NTRANatera, Inc.1.62%86,013
18IDXXIDEXX Laboratories, Inc.1.59%29,150
19BTSGBrightSpring Health Services, Inc.1.54%482,157
20INSMInsmed Incorporated1.54%120,502
21RPRXRoyalty Pharma plc1.49%440,990
22EBR: UCBUCB SA1.44%58,259
23UNHUnitedHealth Group Incorporated1.38%59,237
24BBIOBridgeBio Pharma, Inc.1.36%216,227
25AXSMAxsome Therapeutics, Inc.1.31%87,700
Showing 25 of 78 holdings
Subscribe to see the full list
As of Jan 31, 2026